An order prohibiting six local companies—Natco Pharma, Hetero, BDR Pharma, Shilpa Medicare, Alkem, and Laurus Labs—from marketing generic versions was recently passed by the Delhi High Court.
A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback